We’re very proud to announce that we have closed a £1.5million investment round, led by global social innovation fund Nesta Impact Investments (NII).
This investment, which was also supported by angel investors and retail investors represented by Seedrs, is the latest addition to NII’s healthcare portfolio and forms part of their strategy to invest in products and services that use patient-centred solutions to help improve health outcomes in the UK.
The funding comes at a critical time to enable Q doctor to increase support during pandemic, helping to keep patients and clinicians safe. We are already playing a key support role in the London COVID-19 Isolation Centre and are working with a significant number of NHS services to increase access to remote clinical advice and support, so now more than ever, we are determined to scale at pace to meet the growing demand for safe, secure, easy to use video consultations.
Manish Miglani, Healthcare Lead at Nesta Impact Investments, and who will join the Q doctor Board, said:
“Nesta’s health investment activity focuses on innovative and scalable technologies that improve health outcomes, reduce health inequalities, and help patients get more tailored care. Q doctor already assists NHS clinicians and patients by integrating with existing NHS systems, rather than seeking to replace NHS GP services: this was key to our investment decision. We are excited to have led this very significant investment round, particularly at this pressing time, and look forward to supporting Q doctor’s scale-up plans.”
Chris Whittle, Founder and Chief Executive Officer of Q doctor added:
“I am delighted to have completed our funding round led by Nesta Impact Investments and being able to bring in pro-NHS individuals at the same time via Seedrs. Q doctor has achieved national firsts in supporting 111, outpatient departments, hundreds of GP practices, and most recently London’s first COVID-19 Isolation Centre at Heathrow. Our solution, from a clinically led company, is tried and tested across the NHS; this funding is well timed to resource our rapid growth, as we support the NHS through the COVID-19 crisis at scale”.